The main purpose of this pilot study is to examine the outcome of a combined bone marrow and kidney transplant from a partially matched related (haploidentical or "haplo") donor. The aim of the combined transplant is to treat both underlying blood disorders and kidney diseases. Ten people are expected to participate in this study.

More information: clinicaltrials.gov, ITHANET Clinical Trials